Medication Guide for efgartigimod: Detailed explanation of dosage control and usage
Efgartigimod is an innovative drug used to treat systemic myasthenia gravis in adults. It modulates the immune system and reduces the production of pathogenic antibodies, thereby alleviating the symptoms of muscle weakness and fatigue in patients. Regarding the dosage and usage of igamod, the following is a detailed introduction:
Igamod is usually used in the form of an injection and must be taken under the guidance of a doctor. The recommended dose is 10 mg per kilogram of body weight, administered by intravenous infusion, and the infusion time is approximately 1 hour. Such dosage design aims to ensure that the drug can achieve effective therapeutic concentrations in the body while reducing the occurrence of adverse reactions.

For patients weighing 120 kilograms or more, the recommended dose of igamod will be adjusted accordingly to 1,200 mg per infusion, that is, 3 bottles of drug, to ensure the adequacy and safety of treatment.
In terms of treatment cycle, it is usually recommended to infuse Igamod once a week for continuous use for 4 weeks. Such a cycle design helps maintain a stable concentration of the drug in the body, thereby continuing to exert its therapeutic effect. However, specific treatment cycles and dosages may be adjusted based on the patient's specific condition, physical condition, and response to treatment.
During the period of using igamod, doctors will closely monitor the patient's condition changes and adverse reactions, and adjust the treatment plan as necessary. Patients should also strictly follow the doctor's instructions and do not increase or decrease the dosage or change the medication method on their own.
In addition, there are some things to note when using Igamod. For example, before using a drug, a doctor will perform a thorough evaluation to ensure that the patient is suitable for the treatment. At the same time, patients should be followed up regularly during the medication period so that doctors can understand changes in their condition and adjust treatment plans in a timely manner. If any discomfort or adverse reactions occur, patients should communicate with their doctor promptly and seek medical help.
Reference link:https://www.goodrx.com/vyvgart/what-is#dosage
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)